Abstract
Wet sol–gel silica matrices produced under different hydrolysis conditions were used as delivery devices to the active principle of an antiepileptic drug (phenytoin sodium), encapsulated during the condensation stage. Post-incorporation into dry silica powder was an alternative loading procedure. It was proven by infrared spectroscopy that neither the silica network nor the drug loose integrity by encapsulation. The kinetics of in vitro drug release was studied at 37 °C, to water and to artificial cerebrospinal fluid (ACSF). Emphasis has been given to the release to ACSF under dynamic conditions (with fluid renovation, emulating what occurs in the brain). Different delivery regimes were identified and correlated with the loading method and the matrix structure. Matrices with lower total porosity and smaller average pore size proved to be better for a long term release. Renovation of ACSF is relevant to assure a constant concentration of phenytoin in the vicinity of the device.
Similar content being viewed by others
References
Yokoyama M, Okano T (1996) Adv Drug Delivery Rev 21:77
Ulrich KE, Cannizzaro SM, Langer RS et al (1999) Chem Rev 99:3181. doi:10.1021/cr940351u
Rösler A, Vandermuelen GWM (2001) Adv Drug Delivery Rev 53:95
Kataoka K, Harada A, Nagasaki Y (2001) Adv Drug Delivery Rev 47:113
Guo X, Szoka F (2003) Acc Chem Res 36:335
Yang Q, Wang SC, Fan PW et al (2005) Chem Mater 17:5999
Song S-W, Hidajat K, Kawi S (2005) Langmuir 21:9568. doi:10.1021/la051167e
Qu FY, Zhu GS, Lin HM et al (2006) Eur J Inorg Chem 2006:3943. doi:10.1002/ejic.200501035
Yang H, Kao WJ (2006) Pharm Res 23:205. doi:10.1007/s11095-005-8417-z
Zan J, Chen H, Jiang G et al (2006) J Appl Polym Sci 101:1892. doi:10.1002/app.23613
Sandolo C, Coviello T, Matricardi P et al (2007) Eur Biophys J 36:693
Jiang Z, You Y, Deng X et al (2007) Polymer 48:4786
Determan MD, Cox JP, Mallapragada SK (2007) J Biomed Mater Res A 81:326
Suzuki A, Tanaka T (1990) Nature 346:345
Jones CD, Lyon LA (2000) Macromolecules 33:8301
Kim HJ, Lee JH, Lee M (2005) Angew Chem Int Ed 44:5810
Chen S, Singh J (2005) Pharm Dev Technol 10:319
Vallet-Regí M, Rámila A, del Real RP et al (2001) Chem Mater 13:308
Charnay C, Begu S, Tourne-Peteilh C et al (2004) Eur J Pharm Biopharm 57:533
Zeng W, Qian XF, Zhang YB et al (2005) Mater Res Bull 40:766
Izquierdo-Barba I, Martinez A, Doadrio AL et al (2005) Eur J Pharm Sci 26:365
Fagundes LB, Sousa TGF, Sousa A et al (2006) J Non-Cryst Solids 352:3496
Barbé C, Bartlett J, Kong L et al (2004) Adv Mater 16:1959
Vallet-Regí M, Balas F, Colilla M et al (2007) Solid State Sciences 9:768
Zhu Y, Shi J, Chen H et al (2005) Mic Mes Mater 84:218
Zhu Y, Shi J, Shen W et al (2005) Nanotechnology 16:2633
Shula R, Falaize S, Lee MH et al (2002) Biomaterials 23:3113
Kortesuo P, Ahola M, Kangas M et al (2001) Int J Pharm 221:107
Jiang Y, Wu Z, You L et al (2006) Colloids Surf B Biointerfaces 49:55
Ahola M, Kortesuo P, Kangasniemi I et al (2000) Int J Pharm 195:219
Kortesuo P, Ahola M, Karlsson S et al (2000) Biomaterials 21:193
Radin S, Ducheyne P, Kamplain T et al (2001) J Biomed Mater Res 57:313
Aughenbaugh W, Radin S, Ducheyne P (2001) J Biomed Mater Res 57:321
Hwang YJ, Oh C, Oh SG (2005) J Control Release 106:339
Falaize S, Radin S, Ducheyne P (1999) J Am Ceram Soc 82:969
Livage J (1997) Curr Opin Solid State Mater Sci 2:132
Fidalgo A, Ilharco LM (2004) Chem Eur J 10:392
Meixner DL, Dyer PN (1999) J Sol–Gel Sci Technol 14:223
Viitala R, Jokinen M, Maunu SL et al (2005) J Non-Cryst Solids 351:3225
Viitala R, Jokinen M, Tuusa S et al (2005) J Sol–Gel Sci Technol 36:147
Siepmann J, Göpferich A (2001) Adv Drug Del Rev 48:229
Göpfrich A (1997) Biomaterials 18:397
Göpferich A, Langer R (1995) J Control Release 33:55
Lee JW, Gardella JA, Hicks W et al (2003) Pharm Res 20:149
Fidalgo A, Rosa ME, Ilharco LM (2003) Chem Mater 15:2186
Kroeg AF, Kjeldsberg CR (1991) In: Henry JB (ed) Clinical diagnosis and management by laboratory methods. Saunders, Toronto
Brown PD, Speake T, Davies SL et al (2004) In: Zheng W, Chodobski A (eds) The blood cerebrospinal fluid barrier. CRC Press, Boca Raton
Fidalgo A, Ilharco LM (2005) Mic Mes Mater 84:229
Trewyn BG, Whitman CM, Lin VSY (2004) Nano Lett 4:2139
Higushi T (1961) J Pharm Sci 50:874
Talukdar MM, Kinget R (1997) Int J Pharm 151:99
Peppas NA (1985) Pharm Acta Helv 60:110
Peppas NA, Korsmeyer RW (1986) In: Peppas NA (ed) Hydrogels in medicine and pharmacy, vol 3. CRC Press, Boca Raton
Siepmann J, Peppas NA (2001) Adv Drug Delivery Rev 48:139
Ritger PL, Peppas NA (1987) J Control Release 5:23
Ritger PL, Peppas NA (1987) J Control Release 5:37
Andrade JS Jr, Street DA, Shibusa Y et al (1997) Phys Rev E 55:772
Havlin S, Bundle A (1996) In: Bundle A, Havlin S (eds) Fractals and disordered systems, 2nd edn. Springer, Heidelberg
Domingo JL (2006) J Alzheimers Dis 10:331
Acknowledgments
This work was supported by Fundação para a Ciência e a Tecnologia (FCT), Project POCI/QUI/60918/2004. Alexandra Fidalgo acknowledges Post-doc grant SFRH/BPD/20234/2004.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fidalgo, A., Lopez, T.M. & Ilharco, L.M. Wet sol–gel silica matrices as delivery devices for phenytoin. J Sol-Gel Sci Technol 49, 320–328 (2009). https://doi.org/10.1007/s10971-008-1880-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10971-008-1880-3